Diagnostic Companies Aim to Bring Routine Testing to Point of Care, but Face Significant Hurdles
NEW YORK - Some five years after the collapse of Theranos, a handful of diagnostic companies are once again trying to bring routine clinical testing to the point of care...
Genalyte Inc published this content on September 20, 2023, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 15, 2026 at 07:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]